Post job

Sigilon Therapeutics overview

Industry
Biotechnology
Revenue
Headquarters
Employees
121
Founded in
Website
Organization type
Public
Social media
Sigilon Therapeutics is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases.
Based in Cambridge, MA, Sigilon Therapeutics is a small health care company with only 121 employees and an annual revenue of $12.9M.

Sigilon Therapeutics's mission statement

To create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

Sigilon Therapeutics employee reviews

Be the first to review!

Do you work at Sigilon Therapeutics?

Help job seekers learn about working at Sigilon Therapeutics

On this page

Be the first to review Sigilon Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Sigilon Therapeutics?

The team at Sigilon Therapeutics

  • The founders of Sigilon Therapeutics are Omid Veiseh, Arturo Vegas, Daniel G. Anderson and José Oberholzer.
  • The key people at Sigilon Therapeutics are Rogerio Vivaldi Coelho, Omid Veiseh and Arturo Vegas.
Key people
Rogerio Vivaldi Coelho
Omid Veiseh
Arturo Vegas
Daniel G. Anderson
José Oberholzer

Rate the Sigilon Therapeutics' inclusivity.

Zippia waving zebra

Do you work at Sigilon Therapeutics?

Is Sigilon Therapeutics' workforce diverse and inclusive?

Sigilon Therapeutics financial performance

9.1
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Sigilon Therapeutics currently has 12.9M in revenue. Sigilon Therapeutics's most recent quarter produced 5.9m (q2'2023).

Sigilon Therapeutics annual revenue

$14M
$11M
$8M
$6M
$3M
$0
2019
2020
2021
2022

Are you an executive, HR leader, or brand manager at Sigilon Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Sigilon Therapeutics FAQs

Search for jobs

Zippia gives an in-depth look into the details of Sigilon Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Sigilon Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Sigilon Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Sigilon Therapeutics. The data presented on this page does not represent the view of Sigilon Therapeutics and its employees or that of Zippia.

Sigilon Therapeutics may also be known as or be related to SIGILON THERAPEUTICS, INC., Sigilon, Sigilon Therapeutics, Sigilon Therapeutics Inc and Sigilon Therapeutics, Inc.